Covered recipient · General Payments record
SUMMER ELIZABETH GAREY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$3,720.40
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,996.00 | 1 |
| Food and Beverage | $1,260.50 | 13 |
| Education | $83.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SOBI, INC | $2,113.04 | 2 |
| E.R. Squibb & Sons, L.L.C. | $343.42 | 3 |
| Merck Sharp & Dohme Corporation | $326.85 | 3 |
| Incyte Corporation | $263.19 | 4 |
| JAZZ PHARMACEUTICALS INC. | $165.10 | 2 |
| BeiGene USA, Inc. | $128.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BeiGene USA, Inc. | $128.89 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120865600 | CMS |
| E.R. Squibb & Sons, L.L.C. | $122.07 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101305379 | CMS |
| E.R. Squibb & Sons, L.L.C. | $122.75 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101305403 | CMS |
| E.R. Squibb & Sons, L.L.C. | $98.60 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101305405 | CMS |
| Incyte Corporation | $102.84 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141293032 | CMS |
| Incyte Corporation | $83.99 | 05/08/2024 | Education | Undisputed | 01/23/2026 | 1141243638 | CMS |
| Incyte Corporation | $16.85 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141266017 | CMS |
| Incyte Corporation | $59.51 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141320017 | CMS |
| JAZZ PHARMACEUTICALS INC. | $16.44 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151312619 | CMS |
| JAZZ PHARMACEUTICALS INC. | $148.66 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151312617 | CMS |
| Merck Sharp & Dohme LLC | $119.00 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141801450 | CMS |
| Merck Sharp & Dohme LLC | $116.97 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141901708 | CMS |
| Merck Sharp & Dohme LLC | $90.88 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141801264 | CMS |
| SOBI, INC | $117.04 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141427115 | CMS |
| SOBI, INC | $1,996.00 | 12/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141427817 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.